Immunopharmacology

Hardcover | March 5, 2013

byDavid J WebbEditorDavid J Webb

not yet rated|write a review
This new volume of Advances in Pharmacology explores the current state of Alzheimer's disease research and therapeutics. Chapters cover such topics as the B cell targeted therapies , Lymphotoxin family receptors in inflammation , and allergic inflammation and thymic stromal lymphopoietin . With a variety of chapters and the best authors in the field, the volume is an essential resource for pharmacologists, immunologists and biochemists alike. Explores the current state of Alzheimer's disease research and therapeutics Chapters cover a variety of topics such as the B cell targeted therapies, lymphotoxin family receptors in inflammation, and allergic inflammation and thymic stromal lymphopoietin With the best authors in the field, the volume is an essential resource for pharmacologists, immunologists and biochemists alike

Pricing and Purchase Info

$321.09 online
$397.69 list price (save 19%)
In stock online
Ships free on orders over $25

From the Publisher

This new volume of Advances in Pharmacology explores the current state of Alzheimer's disease research and therapeutics. Chapters cover such topics as the B cell targeted therapies , Lymphotoxin family receptors in inflammation , and allergic inflammation and thymic stromal lymphopoietin . With a variety of chapters and the best author...

Format:HardcoverDimensions:352 pages, 9 × 6 × 0.98 inPublished:March 5, 2013Publisher:Academic PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0124047173

ISBN - 13:9780124047174

Look for similar items by category:

Customer Reviews of Immunopharmacology

Reviews

Extra Content

Table of Contents



      1. Redefining Approaches to Asthma: Developing Targeted Biologic Therapies
      2. Protein Therapeutics Targeted at the TNF Superfamily
      3. Immunopharmacology of Lipid A Mimetics
      4. The Biology of Thymic Stromal Lymphopoietin (TSLP)
      5. Eicosanoids in Metabolic Syndrome
      6. The Yin and Yang of Protein Kinase C-theta (PKCq): A Novel Drug Target for Selective Immunosuppression